Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.738 EUR
−39.70 M EUR
30.06 M EUR
45.83 M
About NANOBIOTIX
Sector
Industry
CEO
Laurent Lévy
Website
Headquarters
Paris
Founded
2003
ISIN
FR0011341205
FIGI
BBG003CRPJP4
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NANO is 3.518 EUR — it has decreased by −0.61% in the past 24 hours. Watch NANOBIOTIX stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange NANOBIOTIX stocks are traded under the ticker NANO.
NANO stock has fallen by −7.06% compared to the previous week, the month change is a −18.87% fall, over the last year NANOBIOTIX has showed a −34.24% decrease.
We've gathered analysts' opinions on NANOBIOTIX future price: according to them, NANO price has a max estimate of 16.00 EUR and a min estimate of 9.50 EUR. Watch NANO chart and read a more detailed NANOBIOTIX stock forecast: see what analysts think of NANOBIOTIX and suggest that you do with its stocks.
NANO reached its all-time high on Feb 13, 2014 with the price of 30.282 EUR, and its all-time low was 1.612 EUR and was reached on Apr 28, 2023. View more price dynamics on NANO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
NANO stock is 4.86% volatile and has beta coefficient of 1.15. Track NANOBIOTIX stock price on the chart and check out the list of the most volatile stocks — is NANOBIOTIX there?
Today NANOBIOTIX has the market capitalization of 168.56 M, it has decreased by −8.21% over the last week.
Yes, you can track NANOBIOTIX financials in yearly and quarterly reports right on TradingView.
NANOBIOTIX is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
NANO earnings for the last half-year are −0.46 EUR per share, whereas the estimation was −0.46 EUR, resulting in a 0.00% surprise. The estimated earnings for the next half-year are −0.63 EUR per share. See more details about NANOBIOTIX earnings.
NANOBIOTIX revenue for the last half-year amounts to 9.30 M EUR, despite the estimated figure of 9.30 M EUR. In the next half-year revenue is expected to reach 6.00 M EUR.
NANO net income for the last half-year is −21.87 M EUR, while the previous report showed −11.60 M EUR of net income which accounts for −88.54% change. Track more NANOBIOTIX financial stats to get the full picture.
No, NANO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 102.00 employees. See our rating of the largest employees — is NANOBIOTIX on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NANOBIOTIX EBITDA is −26.81 M EUR, and current EBITDA margin is −96.04%. See more stats in NANOBIOTIX financial statements.
Like other stocks, NANO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NANOBIOTIX stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NANOBIOTIX technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NANOBIOTIX stock shows the strong sell signal. See more of NANOBIOTIX technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.